Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for URAC, INC. · Non-profit accreditation entity for healthcare organizations.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 14, 2026
Income
$70,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 6609
    Pharmacists Fight Back in Medicare and Medicaid Act
  • HR 6610
    Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
 Lobbying activity 3
Medicare/Medicaid

Issues related to health care accreditation, Medicare Advantage plans (including Medicare Advantage Special Needs Plans (SNP) reviews), telehealth, and mental health parity. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back in Medicare and Medicaid Act (H.R. 6609). Issues related to the implementation and use of artificial intelligence in health care, including the role of accreditation.

Health Issues

Issues related to health care accreditation, telehealth, mental health parity, and Medicare Advantage plans. Issues related to reforms to the Organ Procurement and Transplantation Network (OPTN), including the role of accreditation. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back in Medicare and Medicaid Act (H.R. 6609) and the Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] (H.R. 6610). Issues related to the implementation and use of artificial intelligence in health care, including the role of accreditation.

Budget/Appropriations

Issues related to telehealth accreditation, including congressional encouragement of HHS and HRSA to utilize telehealth accreditation to ensure high quality care for patients.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem